Piramal Pharma Ltd
NSE:PPLPHARMA
Wall Street
Price Targets
PPLPHARMA Price Targets Summary
Piramal Pharma Ltd
According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 215.83 INR with a low forecast of 176.75 INR and a high forecast of 299.25 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PPLPHARMA's stock price target?
Price Target
215.83
INR
According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 215.83 INR with a low forecast of 176.75 INR and a high forecast of 299.25 INR.
What is Piramal Pharma Ltd's Revenue forecast?
Projected CAGR
9%
For the last 3 years the compound annual growth rate for Piramal Pharma Ltd's revenue is 44%. The projected CAGR for the next 3 years is 9%.
What is Piramal Pharma Ltd's Operating Income forecast?
Projected CAGR
13%
For the last 3 years the compound annual growth rate for Piramal Pharma Ltd's operating income is -7%. The projected CAGR for the next 3 years is 13%.
What is Piramal Pharma Ltd's Net Income forecast?
Projected CAGR
96%
For the last 3 years the compound annual growth rate for Piramal Pharma Ltd's net income is -36%. The projected CAGR for the next 3 years is 96%.
